Merck MRK
NYSE MRK
$152.52 +3.53 (+2.37%)
As of: Aug 21, 2026 · 3:59 PM EDT

Merck (MRK) Finished Goods (2009 - 2012)

Merck (MRK) posted quarterly Finished Goods of $1.8 billion for Q2 2012, up 25.56% year-over-year from $1.4 billion in Q3 2011, and up 1.63% quarter-over-quarter from $1.8 billion in Q1 2012.

Merck (MRK) Finished Goods (2009 - 2012) Analysis & Trends

Merck (MRK) has reported Finished Goods for 4 consecutive years, with $1.8 billion the latest figure, recorded in Q2 2012.

  • In Q2 2012, Finished Goods rose 25.56% year-over-year to $1.8 billion; the TTM figure through Jun 2012 stood at $1.8 billion (up 25.56% YoY), while the FY2011 annual figure was $2.0 billion, up 33.63% from the prior year.
  • Finished Goods rose to $1.8 billion in Q2 2012 per MRK's latest filing, from $1.8 billion in the prior quarter.
  • Across five years, Finished Goods topped out at $2.5 billion in Q4 2009 and bottomed at $1.4 billion in Q1 2011.
  • Historically, Finished Goods has averaged $1.8 billion across 4 years, with a median of $1.8 billion in 2012.
  • Annual changes were most pronounced in 2010 — Finished Goods tumbled 39.82% — and 2011, when it jumped 33.63%.
  • Merck's Finished Goods stood at $2.5 billion in 2009, then sank by 39.82% to $1.5 billion in 2010, then jumped by 33.63% to $2.0 billion in 2011, then declined by 8.83% to $1.8 billion in 2012.
  • Business Quant data shows MRK's Finished Goods at $1.8 billion in Q2 2012, $1.8 billion in Q1 2012, and $2.0 billion in Q4 2011.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn
10 Sanofi 55.07 Bn 47.69 Bn 10.79 Bn

Historic Data

Download Data
DateValue
Jun 30, 2012 1.81 Bn
Mar 31, 2012 1.78 Bn
Dec 31, 2011 1.98 Bn
Sep 30, 2011 1.64 Bn
Jun 30, 2011 1.44 Bn
Mar 31, 2011 1.38 Bn
Dec 31, 2010 1.48 Bn
Sep 30, 2010 1.95 Bn
Jun 30, 2010 1.88 Bn
Dec 31, 2009 2.47 Bn